This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Determining the right percentage of income to save for retirement is crucial for millennials. Find out the ideal savings rate for a secure future.
24,766 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
A director at The Cheesecake Factory recently disclosed a sizable stock move. This guide breaks down what that inside...
The AI infrastructure boom has Nvidia leading, but Alphabet's end-to-end AI stack and TPU ecosystem could reshape the...
As Rocket Lab nears a pivotal earnings print, investors are quietly growing more bullish. This piece breaks down why ...
A focused look at Toast's Q1 2026 results and what they imply for toast (tost) 2026 earnings. Expect discussion of re...
What would it take for the next company to reach a $5 trillion market cap? This article breaks down the path, the can...
As AI accelerates, the Microsoft-OpenAI relationship faces shifts. This piece explains why microsoft distancing itsel...
A recent insider sale of 5,595 Hilton Grand Vacations shares has investors asking what it means for the stock. This g...
Investors are torn over a high-growth AI stock. This article breaks down the split, lays out the bull case, and shows...
Investors are weighing Plug Power's turnaround against hydrogen hype. This guide breaks down the signals, risks, and ...
When a hedge fund makes a substantive move in Genpact, it prompts investors to reassess the stock. This article break...
Insider moves can shape sentiment, but they aren’t a stand-alone signal. This deep dive explains what c3.ai's sold 17...